急性ST段抬高型心肌梗死PCI治疗的研究进展  

Research Progress in PCI Treatment of Acute ST-Segment Elevation Myocardial Infarction

作　　者：王世锋[1] 孙伟[1] WANG Shifeng;SUN Wei(Department of Cardiology,Dalian Third People′s Hospital,Dalian 116033,China)

机构地区：[1]大连市第三人民医院心内科,辽宁大连116033

出　　处：《医学综述》2021年第5期952-956,共5页Medical Recapitulate

摘　　要：近年来,经皮冠状动脉介入(PCI)治疗急性ST段抬高型心肌梗死(STEMI)得到快速发展与应用。PCI治疗包括直接PCI治疗和易化PCI治疗,其中易化PCI治疗扩大了PCI的治疗范围。两种PCI治疗均可改善STEMI患者的心肌血流灌注,且治疗效果确切。虽然PCI治疗可有效再通血管,但仍面临再狭窄的问题,不同材质支架的应用使支架内再狭窄发生率得到降低和控制。如何防治支架内再狭窄、支架内血栓形成、冠状动脉穿孔等并发症是今后STEMI患者PCI治疗研究的重点。In recent years,percutaneous coronary intervention(PCI)has been rapidly developed and applied in the treatment of acute ST segment elevation myocardial infarction(STEMI).PCI treatment includes direct PCI treatment and facilitated PCI treatment,and the facilitated PCI treatment has expanded the scope of PCI treatment.Two kinds of PCI treatment can both improve myocardial perfusion in STEMI patients,and the efficacy is exact.Although PCI treatment can effectively recanalize vessels,it still faces the problem of restenosis,and the application of stents with different materials can reduce and control the incidence of in stent restenosis.How to prevent and treat the complications such as in-stent restenosis,in-stent thrombosis,coronary artery perforation and so on is still the key of research on PCI treatment for STEMI patients in the future.

关 键 词：急性ST段抬高型心肌梗死 经皮冠状动脉介入 支架 并发症 

分 类 号：R542.22[医药卫生—心血管疾病]